Impact of Lifestyle Interventions on Brain Imaging and Cognitive Outcomes

Recent research published in JAMA Neurology has investigated the influence of a structured, multidomain lifestyle intervention on various brain imaging biomarkers and cognitive outcomes. The POINTER Imaging Ancillary Study explored whether lifestyle modifications could alter brain changes associated with Alzheimer's disease (AD), cerebrovascular disease, and neurodegeneration, and the potential impact on global cognition.

In this randomized clinical trial, 983 participants aged 60 to 79 years and meeting specific risk criteria for cognitive decline were enrolled. Participants were part of the larger 2-year US POINTER trial, with neuroimaging data collected from five clinical sites across the United States. The study aimed to determine if a lifestyle intervention could affect brain changes and if certain brain imaging biomarkers could predict cognitive improvements.

Participants were divided into two groups: those receiving a structured intervention and those following a self-guided option. Both approaches emphasized increased physical and cognitive activities, improved nutrition, social interaction, and management of cardiovascular health, but differed in intensity and levels of accountability.

The primary imaging outcomes focused on four key measures: global β-amyloid (Aβ) burden, tau burden in the entorhinal cortex, hippocampal volume, and white matter hyperintensity volume. Additionally, a global cognitive composite was used as the primary measure for cognitive outcomes.

Overall, the study found no significant differences between the structured and self-guided intervention groups in terms of changes to the imaging biomarkers or cognitive outcomes over time. However, specific at-risk brain imaging characteristics, such as lower baseline hippocampal volume and greater medial temporal tau accumulation, were associated with better cognitive outcomes for those in the structured intervention group. These characteristics did not show any adverse effects on Aβ status or accumulation.

The findings suggest that while the lifestyle intervention does not directly alter brain biomarker trajectories or Aβ pathology, it offers cognitive benefits for certain subgroups of older adults with specific risk profiles. Notably, those with lower hippocampal volumes experienced more significant cognitive benefits from the structured intervention compared to the self-guided approach.

This study underscores the potential for lifestyle modifications to improve cognitive health in older adults, especially those with particular brain vulnerabilities. Despite not influencing brain biomarker changes, the intervention highlights the importance of targeted strategies in enhancing cognitive outcomes among populations at risk.